• A
• B
• C
• D
• E
• F
• G
• H
• I
• K
• L
• M
• N
• O
• P
• R
• S
• T
• U
• V
• Z

Nivolumab (Opdivo®) for advanced or metastatic gastric, gastro oesophageal junction or oesophageal adenocarcinoma (1L). HTA ID: 21049.

Nivolumab (Opdivo®) for advanced renal cell carcinoma

Nivolumab (Opdivo®) for classical Hodgkin Lymphoma

Nivolumab (Opdivo®) for head and neck cancer

Nivolumab (Opdivo®) for Melanoma

Nivolumab (Opdivo®) for non-squamous NSCLC

Nivolumab (Opdivo®) for NSCLC

Nivolumab (Opdivo®) for urothelial carcinoma

Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®)

Nivolumab (Opdivo®) in combination with ipilimumab (Yervoy®) (Colorectal cancer). HTA ID: 21023